The global glaucoma market reached US$ 8.36 billion in 2023 and is expected to reach US$ 12.77 billion by 2031, growing at a CAGR of 5.5% during the forecast period... Read More
Author: DataM Intelligence
The Global age-related vision dysfunction drugs market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing at a CAGR of YY% during... Read More
The Global Crohn’s Disease Market reached US$ 11.82 billion in 2023 and is expected to reach US$ 17.15 billion by 2031, growing at a CAGR of 4.8% during the forecast... Read More
The global migraine drugs market reached US$ 10.90 billion in 2023 and is expected to reach US$ 23.70 billion by 2031, growing at a CAGR of 10.3% during the forecast... Read More
The Global Cystic Fibrosis Market reached US$ 10.96 billion in 2023 and is expected to reach US$ 26.58 billion by 2031, growing at a CAGR of 11.8% during the forecast... Read More
In the global NASH/MASH treatment market, Rezdiffra generated US$62.2 million in Q3 after its launch in April 2024. If the European launch becomes successful in 2H of 2025, Rezdiffra is... Read More